CalciMedica, Inc. (CALC) announced it has regained compliance with The Nasdaq Stock Market's minimum bid price requirement, resolving a previous deficiency notice. The company received confirmation from Nasdaq on September 15, 2026, stating that the matter is now closed and the company is in compliance with Listing Rule 5550(a)(2).
Key Details
- Compliance Period: The company's common stock maintained a closing bid price of $1.00 or greater for 10 consecutive business days, from August 31, 2026, to September 14, 2026.
- Original Notice: CalciMedica was first notified of non-compliance on March 16, 2026, after its stock price remained below $1.00 for 30 consecutive business days.
- Current Status: As of this filing, the company has no outstanding deficiency notices from Nasdaq, removing the immediate risk of delisting.